ScripGilead Sciences’ Yeytuo (lenacapavir) and Eli Lilly’s Kisunla (donanemab) are among the drugs that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for
Pink SheetThe European Medicines Agency has recommended that Gilead Sciences’ Yeytuo (lenacapavir), for preventing HIV, and 13 other new drugs should be granted pan-EU marketing authorization, but it has advise
ScripNot quite two years after raising $175m in series C cash , inhaled respiratory therapy-focused Avalyn Pharma revealed on July 22 that it has raised a $100m series D round that CEO Lyn Baranowski said
Pink SheetGilead Sciences could learn this week whether the European Medicines Agency will recommend that lenacapavir should be approved for marketing as a twice-yearly preventative option for HIV in the EU as